Fred Hassan

Fred Hassan "joined Warburg Pincus in 2009 as a Senior Advisor and focuses on the firm’s healthcare investment activities. Mr. Hassan served as chairman and CEO of Schering-Plough Corporation from 2003 until its acquisition by Merck & Co., Inc. on November 3, 2009. Before joining Schering-Plough, he served as chairman and CEO of Pharmacia Corporation until the company was acquired by Pfizer Inc. in 2003. From 1997 to 2000, Mr. Hassan was CEO of Pharmacia & Upjohn, Inc., which merged with Monsanto Company in 2000 to become Pharmacia Corporation. From 1972 to 1997, he served in various senior management roles at major pharmaceutical companies. Mr. Hassan recently joined the Board of Directors of Bausch & Lomb and Time Warner Inc. He is also the lead director on the Board of Avon Products, Inc., where he has served since 1999. At Warburg Pincus, he advises the Healthcare Group and provides strategic counsel across the firm's portfolio. Mr. Hassan received his B.S. from the Imperial College of Science and Technology at the University of London and an M.B.A. from Harvard Business School."

Related Sourcewatch

 * Stephen Evans-Freke - former advisor